Soros Fund Management Q2 2024 13F Shows Exited 1.36M Vestis Shares, 251.8K Freeport-McMoRan Shares, 30.6K Micron Shares, 1.4M Snap Shares, 313.85K Viper Energy Shares, 16.9K NextEra Energy Shares, 1.05K United Therapeutics Shares, And 50K 3M Shares
Portfolio Pulse from Benzinga Newsdesk
Soros Fund Management's Q2 2024 13F filing reveals the fund has exited positions in several companies, including Vestis, Freeport-McMoRan, Micron, Snap, Viper Energy, NextEra Energy, United Therapeutics, and 3M.

August 14, 2024 | 8:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Soros Fund Management has exited its position in Freeport-McMoRan, selling 251.8K shares.
The sale of shares by Soros Fund Management could signal a bearish outlook, potentially leading to a short-term price decline.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Soros Fund Management has exited its position in 3M, selling 50K shares.
The sale of 3M shares by Soros Fund Management could indicate a lack of confidence, potentially leading to a short-term price decline.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Soros Fund Management has exited its position in Micron, selling 30.6K shares.
The exit from Micron by Soros Fund Management may indicate a negative outlook, potentially leading to a short-term price decline.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Soros Fund Management has exited its position in NextEra Energy, selling 16.9K shares.
The sale of NextEra Energy shares by Soros Fund Management could indicate a negative outlook, potentially leading to a short-term price decline.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Soros Fund Management has exited its position in Snap, selling 1.4 million shares.
The significant sale of Snap shares by Soros Fund Management could indicate a lack of confidence, potentially leading to a short-term price decline.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Soros Fund Management has exited its position in United Therapeutics, selling 1.05K shares.
The exit from United Therapeutics by Soros Fund Management may signal a bearish outlook, potentially leading to a short-term price decline.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Soros Fund Management has exited its position in Viper Energy, selling 313.85K shares.
The exit from Viper Energy by Soros Fund Management may signal a bearish outlook, potentially leading to a short-term price decline.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Soros Fund Management has exited its position in Vestis, selling 1.36 million shares.
The exit of a significant position by a major fund like Soros Fund Management could indicate a lack of confidence in the stock, potentially leading to a short-term price decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100